Every 10-Q that Launch One Acquisition Corp. Unit (LPAAU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow LPAAU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LPAAU filings page.
Launch One Acquisition Corp., a Cayman Islands SPAC, reported net income of $1.6 million for the quarter and $3.3 million for the six months ended June 30, 2026, down from $1.9 million and $4.2 million in the prior-year periods. Earnings are driven almost entirely by interest on the IPO trust, which held $249.8 million (about $10.86 per public share) at June 30, 2026.
General and administrative expenses were $1.1 million for the first half of 2026, and the company used $0.7 million of cash in operating activities, funded partly by a $1.0 million working capital note from the sponsor carrying an original issue discount and 8% interest. Cash outside the trust was $321,957 with a working capital deficit of $1.67 million.
The previously agreed Minovia Therapeutics business combination was terminated on January 30, 2026, and all related agreements were canceled with mutual releases. On July 10, 2026, shareholders approved extending the deadline to complete a business combination to January 15, 2027, and redemptions of 21,226,389 public shares removed about $229.9 million from the trust. Management discloses that the mandatory liquidation date and limited liquidity raise substantial doubt about the company’s ability to continue as a going concern if no deal is completed within the combination period.
Launch One Acquisition Corp. reported net income of $1,700,072 for the quarter ended March 31, 2026, mainly from interest on $247,617,197 held in its trust account. General and administrative expenses rose to $467,775, while cash outside the trust was $266,001, leaving a working capital deficit of $1,077,733.
The SPAC terminated its previously announced Minovia business combination in January 2026 and is seeking a new target. Management discloses that the July 15, 2026 deadline to complete a deal, combined with limited liquidity, raises substantial doubt about its ability to continue as a going concern.
Launch One Acquisition Corp. is a SPAC formed to complete a business combination, reporting condensed interim financials and transaction disclosures for the quarter ended June 30, 2025. The company completed a $230,000,000 IPO (23,000,000 Units at $10.00 each, including a 3,000,000 over-allotment) and placed $230,000,000 in a Trust Account invested in U.S. Treasury securities and money market funds. There are 17,500,000 Warrants outstanding (11,500,000 Public; 6,000,000 Private Placement). Founder Shares total 5,750,000. The company entered into a Business Combination Agreement to combine with Minovia Therapeutics, including earnout shares of up to 57,500,000 Pubco ordinary shares subject to vesting conditions, a Minimum Cash Condition of at least $23 million, and required Bridge Financing of at least $5 million. Interest earned on the Trust Account was $2,547,714 for the period noted; no withdrawals of interest were made. Deferred underwriting fees of $10,950,000 are payable upon completion of the business combination. The Trust Account investments are classified as held-to-maturity and recorded at amortized cost.